CERO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 18.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $907,649.00

CERo Therapeutics Insider Trading History Chart

CERo Therapeutics Share Price & Price History

^$0.96

▼ -0.3998 (-29.40%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

CERo Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/13/2024	Bioventures Opportunities G Yk	Major Shareholder	Sell	29,989	$6.00	$179,934.00	130,051
12/11/2024	Bioventures Opportunities G Yk	Major Shareholder	Sell	13,438	$8.00	$107,504.00	176,186
12/9/2024	Bioventures Opportunities G Yk	Major Shareholder	Sell	8,505	$11.00	$93,555.00	205,333
12/6/2024	Bioventures Opportunities G Yk	Major Shareholder	Sell	12,368	$12.00	$148,416.00	213,839
10/10/2024	Bioventures Opportunities G Yk	Major Shareholder	Sell	32,500	$10.00	$325,000.00	226,207
9/25/2024	Stuart M Sloan	Major Shareholder	Sell	5,324	$10.00	$53,240.00	210,679

SEC Filings (Institutional Ownership Changes) for CERo Therapeutics (NASDAQ:CERO)

29.64% of CERo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

CERo Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company	Details
2/17/2025	ARCH Venture Management LLC	9,393,561	$0.56M	0.2%	+550.4%	626.237%
2/7/2025	Avantax Planning Partners Inc.	2,585,151	$0.16M	0.0%	+89.9%	171.999%

Data available starting January 2016

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Today's Range

Now: $0.96

$0.93

$1.28

50 Day Range

MA: $2.20

$0.96

$5.82

52 Week Range

Now: $0.96

$0.93

$376.00

Volume

5,992,217 shs

Average Volume

368,173 shs

Market Capitalization

$2.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of CERo Therapeutics?: CERo Therapeutics' top insider investors include:
Bioventures Opportunities G Yk (Major Shareholder)
Stuart M Sloan (Major Shareholder)
Learn More about top insider investors at CERo Therapeutics.
Who are the major institutional investors of CERo Therapeutics?: CERo Therapeutics' top institutional investors include:
ARCH Venture Management LLC — 626.24%
Avantax Planning Partners Inc. — 172.00%
Learn More about top institutional investors of CERo Therapeutics stock.
Which institutional investors are buying CERo Therapeutics stock?: Within the previous quarter, CERO stock was bought by institutional investors including:
ARCH Venture Management LLC
Avantax Planning Partners Inc.